ARCHES Trial “Changes Practice” for Metastatic Hormone-Sensitive Prostate Cancer

The results of the double-blind, phase III trial were presented at the 2019 ASCO Genitourinary Cancers Symposium.

Source: CancerNetwork - February 21, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news